Source:http://linkedlifedata.com/resource/pubmed/id/16934438
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2006-10-18
|
pubmed:databankReference | |
pubmed:abstractText |
This study focuses on the potentiality of a putative probiotic strain, Lactobacillus paracasei A, to survive gastrointestinal (GI) passage and modulate the resident microbiota of healthy infants. In a placebo-controlled study, 26 children aged 12-24 months received 100 g/day of either fermented milk containing strain A or pasteurized yogurt for four weeks. Fecal samples were analyzed before starting the administration, after 1, 3 and 4 weeks of consumption and after washout. The fate of strain A was followed by means of a newly developed PCR targeting a strain-specific genomic marker. The composition and dynamics of fecal microbial communities during the study were analyzed by culturing on selective media and by the PCR-denaturing gradient gel electrophoresis (DGGE) technique using universal and group-specific (Lactobacillus and Bifidobacterium) primers. The variation in enzymatic activities in infant feces during probiotic consumption was also analyzed. Strain A survived in fecal samples in most (92%) of the infants examined after 1 week of consumption, and temporarily dominated the intestinal Lactobacillus community. The administration of L. paracasei A led to a significant increment in the Lactobacillus population, while a moderate effect upon the main bacterial groups in the GI ecosystem was observed. Strain A also affected the diversity of the Lactobacillus and Bifidobacterium populations. The fecal bacterial structure of 1 - 2-year-old infants seems to combine neonate and adult-like features. The microbiota of these subjects promptly responded to probiotic consumption, later restoring the endogenous equilibrium.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0923-2508
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
157
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
857-66
|
pubmed:meshHeading |
pubmed-meshheading:16934438-Cultured Milk Products,
pubmed-meshheading:16934438-DNA, Bacterial,
pubmed-meshheading:16934438-Feces,
pubmed-meshheading:16934438-Gastrointestinal Tract,
pubmed-meshheading:16934438-Humans,
pubmed-meshheading:16934438-Infant,
pubmed-meshheading:16934438-Lactobacillus,
pubmed-meshheading:16934438-Microbial Viability,
pubmed-meshheading:16934438-Molecular Sequence Data,
pubmed-meshheading:16934438-Polymerase Chain Reaction,
pubmed-meshheading:16934438-Probiotics,
pubmed-meshheading:16934438-Random Amplified Polymorphic DNA Technique,
pubmed-meshheading:16934438-Sequence Analysis, DNA
|
pubmed:year |
2006
|
pubmed:articleTitle |
Lactobacillus paracasei A survives gastrointestinal passage and affects the fecal microbiota of healthy infants.
|
pubmed:affiliation |
Department of Science and Technology, University of Verona, Strada Le Grazie, 15, 37134 Verona, Italy.
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|